WHO ICTRP trial
Efficacy of 5% Trisodium Citrate and Low Dose Heparin as Catheter-Locking…
TCTR20231106002 · Thai Clinical Trials Registry (TCTR) · Recruiting
Key facts
| Trial ID | TCTR20231106002 |
|---|---|
| Public title | Efficacy of 5% Trisodium Citrate and Low Dose Heparin as Catheter-Locking Solution for Central Venous Hemodialysis Catheters: A Randomized Controlled Study |
| Scientific title | Efficacy of 5% Trisodium Citrate and Low Dose Heparin as Catheter-Locking Solution for Central Venous Hemodialysis Catheters: A Randomized Controlled Study |
| Primary sponsor | Thammasat University Research Fund |
| Secondary sponsors | No secondary ID |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | Thailand |
| Conditions | Central venous catheter dysfunction (CVC dysfunction) is failure to maintain the prescribed extracorporeal blood flow required for adequate hemodialysis without lengthening the prescribed HD treatment. A catheter locking anticoagulant (CLA)… |
| Interventions | 1. Prepared of using 5 mL of 30% TSC, then added 25 mL of 0.9% sodium chloride (NSS) for 5% TSC. 2. After completing every HD treatment, each lumen of the catheter was flushed with 10 mL of NSS, and then instilled with the assigned CLA… |
| Registration date | Jun 11, 2023 |
| Target size | 216 |
| Secondary IDs | Nil Known |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: